CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.
OBJECTIVE
Increasing age is associated with impaired immune function and in chronic HCV infection specifically, with progressive fibrosis, liver failure, HCC and impaired responses to antiviral therapy. T-lymphocyte telomere length declines with age. We hypothesised that shorter T-lymphocyte telomere length would be associated with poor clinical outcome in HCV infection.


METHODS
Circulating T-lymphocyte telomere length, an objective measure of immune senescence, was measured by flow-FISH in 135 HCV-RNA-positive, treatment-naïve patients and 41 healthy controls in relation to clinical outcome.


RESULTS
Shorter CD4+CD45RO+ T-lymphocyte telomeres were associated with severe fibrosis (p=0.003), independent of male sex (p=0.04), CMV positivity (p=0.003), previous HBV infection (p=0.007), and age (p=ns) in viraemic patients compared to controls. There were inverse correlations between CD4+CD45RO+ telomere length and fibrosis stage (p<0.001), portal tract inflammatory grade (p=0.035), prothrombin time (p<0.001) and bilirubin (p=0.001). One hundred and twenty-four viraemic individuals were followed prospectively to a composite endpoint of death, hepatic decompensation or HCC. Independent of age, those with shorter CD4+CD45RO+ telomeres were less likely to be complication free after 2-years than those with longer telomeres (86% versus 96%, p=0.009) with an age-adjusted hazard ratio of 0.93 (0.90-0.96). In addition, CD4+CD45RO+ telomere length predicted successful antiviral therapy (p=0.001) independent of other factors.


CONCLUSIONS
CD4+ T-lymphocyte telomere length, independent of age, was related to inflammatory grade, fibrosis stage, laboratory indices of severity, subsequent hepatic decompensation and treatment outcome in patients with chronic HCV infection.
Hoare
Matthew
M
Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Gelson
William T H
WT
Das
Abhi
A
Fletcher
Jean M
JM
Davies
Susan E
SE
Curran
Martin D
MD
Vowler
Sarah L
SL
Maini
Mala K
MK
Akbar
Arne N
AN
Alexander
Graeme J M
GJ
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology*; D016022:Case-Control Studies; D005260:Female; D016174:Hepacivirus; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011379:Prognosis; D012044:Regression Analysis; D012720:Severity of Illness Index; D016615:Telomere / Q000473:pathology*; D016896:Treatment Outcome
D000998:Antiviral Agents
Cytometry. 2002 Feb 1;47(2):89-99
11813198
Immunol Rev. 2005 Jun;205:257-68
15882359
Exp Cell Res. 2000 May 1;256(2):578-82
10772830
Eur J Immunol. 2004 Jun;34(6):1570-7
15162426
Eur J Intern Med. 2008 Jun;19(4):266-70
18471675
J Pathol. 2007 Jan;211(2):124-33
17200941
J Immunol. 2007 Sep 15;179(6):4283-91
17785869
Nat Rev Immunol. 2004 Sep;4(9):737-43
15343372
J Gerontol A Biol Sci Med Sci. 1995 Nov;50(6):B378-82
7583794
N Engl J Med. 2006 Dec 7;355(23):2444-51
17151366
Nature. 2003 Nov 13;426(6963):194-8
14608368
J Biol Chem. 2004 Oct 22;279(43):45148-54
15322096
Gut. 2004 Mar;53(3):451-5
14960533
Nat Immunol. 2005 Sep;6(9):873-9
16116467
Blood. 2001 Feb 1;97(3):700-7
11157487
Am J Gastroenterol. 2007 Jul;102(7):1383-91
17403072
Cancer Genet Cytogenet. 2008 Nov;187(1):34-8
18992639
FASEB J. 2002 Jul;16(9):935-42
12087054
J Exp Med. 2004 May 17;199(10):1433-43
15148341
Lancet. 1997 Mar 22;349(9055):825-32
9121257
Blood. 2004 Jan 1;103(1):162-7
12969961
Gastroenterology. 2008 May;134(6):1699-714
18471548
J Clin Immunol. 2004 May;24(3):258-71
15114056
Nat Immunol. 2004 Feb;5(2):133-9
14749784
J Immunol. 2005 Dec 15;175(12):8218-25
16339561
Clin Gastroenterol Hepatol. 2006 Oct;4(10):1271-7
16901770
J Hepatol. 2001 May;34(5):730-9
11434620
Liver Int. 2007 Apr;27(3):335-9
17355454
Lancet. 2003 Feb 1;361(9355):393-5
12573379